February 07, 2020 / 11:48 AM IST
Reported Consolidated quarterly numbers for GlaxoSmithKline Pharmaceuticals are:Net Sales at Rs 778.59 crore in December 2019 down 5.63% from Rs. 825.03 crore in December 2018.
Story continues below Advertisement
Quarterly Net Loss at Rs. 661.16 crore in December 2019 down 583.59% from Rs. 136.72 crore in December 2018.
EBITDA stands at Rs. 140.89 crore in December 2019 down 8.31% from Rs. 153.66 crore in December 2018.
GlaxoSmithKline shares closed at 1,342.95 on February 06, 2020 (NSE) and has given 11.17% returns over the last 6 months and -3.04% over the last 12 months.
GlaxoSmithKline Pharmaceuticals | Consolidated Quarterly Results | in Rs. Cr. |
|
| Dec'19 | Sep'19 | Dec'18 | Net Sales/Income from operations | 778.59 | 882.02 | 825.03 | Other Operating Income | -- | -- | -- | Total Income From Operations | 778.59 | 882.02 | 825.03 | EXPENDITURE | Consumption of Raw Materials | 112.45 | 94.56 | 184.91 | Purchase of Traded Goods | 238.64 | 130.05 | 226.77 | Increase/Decrease in Stocks | -23.34 | 145.26 | -29.10 | Power & Fuel | -- | -- | -- | Employees Cost | 166.69 | 147.47 | 125.55 | Depreciation | 18.33 | 22.70 | 12.04 | Excise Duty | -- | -- | -- | Admin. And Selling Expenses | -- | -- | -- | R & D Expenses | -- | -- | -- | Provisions And Contingencies | -- | -- | -- | Exp. Capitalised | -- | -- | -- | Other Expenses | 159.76 | 170.67 | 179.82 | P/L Before Other Inc., Int., Excpt. Items & Tax | 106.06 | 171.31 | 125.04 | Other Income | 16.50 | 15.88 | 16.58 | P/L Before Int., Excpt. Items & Tax | 122.56 | 187.19 | 141.62 | Interest | 2.98 | 0.92 | 0.05 | P/L Before Exceptional Items & Tax | 119.58 | 186.27 | 141.57 | Exceptional Items | -753.90 | 401.14 | 51.95 | P/L Before Tax | -634.32 | 587.41 | 193.52 | Tax | 26.84 | 84.66 | 56.80 | P/L After Tax from Ordinary Activities | -661.16 | 502.75 | 136.72 | Prior Year Adjustments | -- | -- | -- | Extra Ordinary Items | -- | -- | -- | Net Profit/(Loss) For the Period | -661.16 | 502.75 | 136.72 | Minority Interest | -- | -- | -- | Share Of P/L Of Associates | -- | -- | -- | Net P/L After M.I & Associates | -661.16 | 502.75 | 136.72 | Equity Share Capital | 169.41 | 169.41 | 169.41 | Reserves Excluding Revaluation Reserves | -- | -- | -- | Equity Dividend Rate (%) | -- | -- | -- | EPS Before Extra Ordinary | Basic EPS | -39.03 | 29.68 | -- | Diluted EPS | -39.03 | 29.68 | -- | EPS After Extra Ordinary | Basic EPS | -39.03 | 29.68 | -- | Diluted EPS | -39.03 | 29.68 | -- | Public Share Holding | No Of Shares (Crores) | -- | -- | -- | Share Holding (%) | -- | -- | -- | Promoters and Promoter Group Shareholding | a) Pledged/Encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | b) Non-encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | Source : Dion Global Solutions Limited |
|
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!